Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1997 March 1; 99(5): 1092–1097.
PMCID: PMC507918

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.


Reactivation of herpes simplex virus type 2 (HSV-2) occurs intermittently as perceived clinically and by viral culture. We performed a series of studies to evaluate the frequency and pattern of HSV-2 reactivation using both viral isolation and HSV PCR assay. Daily samples of genital secretions were obtained from 27 HSV-2 seropositive women; a subset of subjects obtained samples while receiving oral acyclovir 400 mg PO twice a day. HSV DNA was detected in genital swab specimens on 28% of 1,410 d compared with 8.1% of days by viral isolation. 11 of 20 women had HSV DNA detected on > 20% of days, 4 on > 50%, and 2 on > 75% of days; in contrast, none of the women shed on > 21% of days by viral isolation. The daily administration of oral acyclovir promptly reduced the frequency of HSV DNA detection by a median of 80%. Within 3-4 d of discontinuing daily acyclovir, HSV DNA again appeared in the genital area. HSV-2 shedding in the genital mucosa occurs much more frequently than previously appreciated. This frequent reactivation likely plays a role in the epidemic spread of genital herpes worldwide.

Full Text

The Full Text of this article is available as a PDF (167K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Corey L, Spear PG. Infections with herpes simplex viruses (2). N Engl J Med. 1986 Mar 20;314(12):749–757. [PubMed]
  • Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 1988 Sep 9;260(10):1429–1433. [PubMed]
  • Hook EW, 3rd, Cannon RO, Nahmias AJ, Lee FF, Campbell CH, Jr, Glasser D, Quinn TC. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis. 1992 Feb;165(2):251–255. [PubMed]
  • Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989 Jul 6;321(1):7–12. [PubMed]
  • Baringer JR. Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med. 1974 Oct 17;291(16):828–830. [PubMed]
  • Stanberry LR. Pathogenesis of herpes simplex virus infection and animal models for its study. Curr Top Microbiol Immunol. 1992;179:15–30. [PubMed]
  • Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994 Dec 1;121(11):847–854. [PubMed]
  • Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983 Jun;98(6):958–972. [PubMed]
  • Sacks SL, Tyrrell LD, Lawee D, Schlech W, 3rd, Gill MJ, Aoki FY, Martel AY, Singer J. Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group. J Infect Dis. 1991 Oct;164(4):665–672. [PubMed]
  • Rattray MC, Corey L, Reeves WC, Vontver LA, Holmes KK. Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding. Br J Vener Dis. 1978 Aug;54(4):262–265. [PMC free article] [PubMed]
  • Adam E, Dreesman GE, Kaufman RH, Melnick JL. Asymptomatic virus shedding after herpes genitalis. Am J Obstet Gynecol. 1980 Aug 1;137(7):827–830. [PubMed]
  • Barton SE, Davis JM, Moss VW, Tyms AS, Munday PE. Asymptomatic shedding and subsequent transmission of genital herpes simplex virus. Genitourin Med. 1987 Apr;63(2):102–105. [PMC free article] [PubMed]
  • Brock BV, Selke S, Benedetti J, Douglas JM, Jr, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990 Jan 19;263(3):418–420. [PubMed]
  • Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med. 1992 Mar 15;116(6):433–437. [PubMed]
  • Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995 Sep 21;333(12):770–775. [PubMed]
  • Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995 Apr;171(4):857–863. [PubMed]
  • Cone RW, Hobson AC, Palmer J, Remington M, Corey L. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis. 1991 Oct;164(4):757–760. [PubMed]
  • Cone RW, Swenson PD, Hobson AC, Remington M, Corey L. Herpes simplex virus detection from genital lesions: a comparative study using antigen detection (HerpChek) and culture. J Clin Microbiol. 1993 Jul;31(7):1774–1776. [PMC free article] [PubMed]
  • Cone RW, Hobson AC, Brown Z, Ashley R, Berry S, Winter C, Corey L. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA. 1994 Sep 14;272(10):792–796. [PubMed]
  • Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. [PMC free article] [PubMed]
  • Dalessio J, Ashley R. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J Clin Microbiol. 1992 Apr;30(4):1005–1007. [PMC free article] [PubMed]
  • Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8–15. [PubMed]
  • Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet. 1994 Aug;10(8):267–274. [PubMed]
  • Wagner EK, Devi-Rao G, Feldman LT, Dobson AT, Zhang YF, Flanagan WM, Stevens JG. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J Virol. 1988 Apr;62(4):1194–1202. [PMC free article] [PubMed]
  • Stevens JG, Haarr L, Porter DD, Cook ML, Wagner EK. Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J Infect Dis. 1988 Jul;158(1):117–123. [PubMed]
  • Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol. 1988 Sep;26(9):1772–1774. [PMC free article] [PubMed]
  • Cone RW, Hobson AC, Huang ML. Coamplified positive control detects inhibition of polymerase chain reactions. J Clin Microbiol. 1992 Dec;30(12):3185–3189. [PMC free article] [PubMed]
  • Hill TJ, Harbour DA, Blyth WA. Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection. J Gen Virol. 1980 Mar;47(1):205–207. [PubMed]
  • Scriba M. Persistence of herpes simplex virus (HSV) infection in ganglia and peripheral tissues of guinea pigs. Med Microbiol Immunol. 1981;169(2):91–96. [PubMed]
  • Rong BL, Pavan-Langston D, Weng QP, Martinez R, Cherry JM, Dunkel EC. Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. Invest Ophthalmol Vis Sci. 1991 May;32(6):1808–1815. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation